Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Norovirus infections in young children in Lusaka Province, Zambia: clinical characteristics and molecular epidemiology.

Howard LM, Mwape I, Siwingwa M, Simuyandi M, Guffey MB, Stringer JS, Chi BH, Edwards KM, Chilengi R.

BMC Infect Dis. 2017 Jan 23;17(1):92. doi: 10.1186/s12879-017-2206-2.

2.

A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.

Beres LK, Tate JE, Njobvu L, Chibwe B, Rudd C, Guffey MB, Stringer JS, Parashar UD, Chilengi R.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S175-82. doi: 10.1093/cid/civ1206.

PMID:
27059353
3.

Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.

Seu L, Mulenga LB, Siwingwa M, Sikazwe I, Lambwe N, Guffey MB, Chi BH.

J Med Virol. 2015 Jul;87(7):1149-57. doi: 10.1002/jmv.24162. Epub 2015 Mar 5.

4.

HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.

Guffey MB, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E, Ramjee G, Mgodi N, Gomez K, Hillier SL, Karim SA; HIV Prevention Trials Network (HPTN) 035 Study Team.

Sex Transm Infect. 2014 Aug;90(5):363-9. doi: 10.1136/sextrans-2014-051537. Epub 2014 Jun 4.

5.

Single genome amplification of proviral HIV-1 DNA from dried blood spot specimens collected during early infant screening programs in Lusaka, Zambia.

Seu L, Mwape I, Guffey MB.

J Virol Methods. 2014 Jul;203:97-101. doi: 10.1016/j.jviromet.2014.03.001. Epub 2014 Mar 22.

6.

Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, Zambia.

Giganti MJ, Limbada M, Mwango A, Moyo C, Mulenga LB, Guffey MB, Mulenga PL, Bolton-Moore C, Stringer JS, Chi BH.

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):120-3. doi: 10.1097/QAI.0b013e31825da11d.

7.

Causes of stillbirth, neonatal death and early childhood death in rural Zambia by verbal autopsy assessments.

Turnbull E, Lembalemba MK, Guffey MB, Bolton-Moore C, Mubiana-Mbewe M, Chintu N, Giganti MJ, Nalubamba-Phiri M, Stringer EM, Stringer JS, Chi BH.

Trop Med Int Health. 2011 Jul;16(7):894-901. doi: 10.1111/j.1365-3156.2011.02776.x. Epub 2011 Apr 7.

8.

Transmission of HIV to infants whose mothers seroconvert postnatally.

Stringer JS, Guffey MB.

BMJ. 2010 Dec 22;341:c6269. doi: 10.1136/bmj.c6269. No abstract available.

PMID:
21177734
9.

Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia.

Mubiana-Mbewe M, Bolton-Moore C, Banda Y, Chintu N, Nalubamba-Phiri M, Giganti M, Guffey MB, Sambo P, Stringer EM, Stringer JS, Chi BH.

Trop Med Int Health. 2009 Oct;14(10):1190-8. doi: 10.1111/j.1365-3156.2009.02360.x. Epub 2009 Aug 25.

10.

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM.

J Exp Med. 2009 Jun 8;206(6):1273-89. doi: 10.1084/jem.20090378. Epub 2009 Jun 1.

11.

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, Manigart O, Mulenga J, Anderson JA, Swanstrom R, Haynes BF, Athreya GS, Korber BT, Sharp PM, Shaw GM, Hahn BH.

J Virol. 2008 Apr;82(8):3952-70. doi: 10.1128/JVI.02660-07. Epub 2008 Feb 6.

12.

Ulceroglandular tularemia in a nonendemic area.

Guffey MB, Dalzell A, Kelly DR, Cassady KA.

South Med J. 2007 Mar;100(3):304-8. Review.

PMID:
17396737
13.

Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors.

Guffey MB, Parker JN, Luckett WS Jr, Gillespie GY, Meleth S, Whitley RJ, Markert JM.

Cancer Gene Ther. 2007 Jan;14(1):45-56. Epub 2006 Sep 22.

PMID:
16990846

Supplemental Content

Loading ...
Support Center